Intranasal Rapamycin Rescues Mice from Staphylococcal Enterotoxin B-Induced Shock
AbstractStaphylococcal enterotoxin B (SEB) and related exotoxins produced by Staphylococcus aureus are potent activators of the immune system and cause toxic shock in humans. Currently there is no effective treatment except for the use of intravenous immunoglobulins administered shortly after SEB exposure. Intranasal SEB induces long-lasting lung injury which requires prolonged drug treatment. We investigated the effects of rapamycin, an immunosuppressive drug used to prevent graft rejection, by intranasal administration in a lethal mouse model of SEB-induced shock. The results show that intranasal rapamycin alone delivered as late as 17 h after SEB protected 100% of mice from lethal shock. Additionally, rapamycin diminished the weight loss and temperature fluctuations elicited by SEB. Intranasal rapamycin attenuated lung MCP-1, IL-2, IL-6, and IFNγ by 70%, 30%, 64%, and 68% respectively. Furthermore, short courses (three doses) of rapamycin were sufficient to block SEB-induced shock. Intranasal rapamycin represents a novel use of an immunosuppressant targeting directly to site of toxin exposure, reducing dosages needed and allowing a wider therapeutic window. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Krakauer, T.; Buckley, M. Intranasal Rapamycin Rescues Mice from Staphylococcal Enterotoxin B-Induced Shock. Toxins 2012, 4, 718-728.
Krakauer T, Buckley M. Intranasal Rapamycin Rescues Mice from Staphylococcal Enterotoxin B-Induced Shock. Toxins. 2012; 4(9):718-728.Chicago/Turabian Style
Krakauer, Teresa; Buckley, Marilyn. 2012. "Intranasal Rapamycin Rescues Mice from Staphylococcal Enterotoxin B-Induced Shock." Toxins 4, no. 9: 718-728.